Atrial fibrillation is a common heart rhythm disorder caused by irregular electrical signals in the upper chambers of the heart. While some people notice symptoms early, others may live with AFib for years without being aware of it. The condition significantly increases the risk of stroke and is a leading cause of hospitalizations worldwide.

AFib is often associated with factors such as high blood pressure, heart disease, diabetes, sleep disorders, and chronic stress. Ongoing clinical research is focused on better understanding these risk factors, improving early detection, and developing new treatment approaches. Participation in clinical trials may offer access to advanced monitoring tools and innovative therapies aimed at enhancing long-term heart health and care.

The causes can vary widely, including diet, infections, lifestyle factors, and underlying medical conditions.

Clinical research focuses on improving diagnosis, treatment, and long-term management of these conditions. Participation may provide access to new therapies and contribute to better care for individuals with digestive and liver disorders.